Max Neeman has initiated a clinical trial for a US based device company to determine the efficacy of the device in removal of plaque in lower limb ischemia in comparison to by-pass surgery. The study is presently enrolling in USA. In India patients will be enrolled within a few months.
For more details on the study, please visit:
http://clinicaltrials-nccs.nlm.nih.gov/ct/show/NCT00504088?order=1 |